NCT06370208View on ClinicalTrials.gov

Prophylactic Effect of Probiotic Streptococcus Salivarius eK12 Against Recurrent Streptococcus Pyogenes Pharyngotonsillitis Infection in Pediatrics

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Streptococcus Pyogenes Pharyngotonsillitis
Interventions
DIETARY_SUPPLEMENT

Probiotic Bactoblis® EVOL (Streptococcus salivarius eK12)

Bactoblis® EVOL: containing one billion CFU of probiotic Streptococcus salivarius eK12

Trial Locations (1)

76090

Liaquat University of Medical and Health Sciences, Jamshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER